174 related articles for article (PubMed ID: 8146182)
21. Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles.
Larson PJ; Camire RM; Wong D; Fasano NC; Monroe DM; Tracy PB; High KA
Biochemistry; 1998 Apr; 37(14):5029-38. PubMed ID: 9538022
[TBL] [Abstract][Full Text] [Related]
22. Simulation model for thrombin generation in plasma.
Willems GM; Lindhout T; Hermens WT; Hemker HC
Haemostasis; 1991; 21(4):197-207. PubMed ID: 1794746
[TBL] [Abstract][Full Text] [Related]
23. A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor Va.
Mesters RM; Heeb MJ; Griffin JH
Biochemistry; 1993 Nov; 32(47):12656-63. PubMed ID: 8251484
[TBL] [Abstract][Full Text] [Related]
24. Direct anticoagulant activity of protein S-C4b binding protein complex in Heerlen heterozygotes and normals.
Heeb MJ; Koenen RR; Fernández JA; Hackeng TM
J Thromb Haemost; 2004 Oct; 2(10):1766-73. PubMed ID: 15456488
[TBL] [Abstract][Full Text] [Related]
25. An anticoagulant RNA aptamer that inhibits proteinase-cofactor interactions within prothrombinase.
Buddai SK; Layzer JM; Lu G; Rusconi CP; Sullenger BA; Monroe DM; Krishnaswamy S
J Biol Chem; 2010 Feb; 285(8):5212-23. PubMed ID: 20022942
[TBL] [Abstract][Full Text] [Related]
26. The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase.
Bukys MA; Orban T; Kim PY; Nesheim ME; Kalafatis M
Thromb Haemost; 2008 Mar; 99(3):511-22. PubMed ID: 18327399
[TBL] [Abstract][Full Text] [Related]
27. Activation of prothrombin in the presence of human umbilical-vein endothelial cells.
Schoen P; Reutelingsperger C; Lindhout T
Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):661-4. PubMed ID: 1531589
[TBL] [Abstract][Full Text] [Related]
28. Lyso-Sulfatide Binds Factor Xa and Inhibits Thrombin Generation by the Prothrombinase Complex.
Yegneswaran S; Banerjee Y; Fernández JA; Deguchi H; Griffin JH
PLoS One; 2015; 10(8):e0135025. PubMed ID: 26263376
[TBL] [Abstract][Full Text] [Related]
29. Ligand specificity of human thrombomodulin. Equilibrium binding of human thrombin, meizothrombin, and factor Xa to recombinant thrombomodulin.
Wu Q; Tsiang M; Lentz SR; Sadler JE
J Biol Chem; 1992 Apr; 267(10):7083-8. PubMed ID: 1313033
[TBL] [Abstract][Full Text] [Related]
30. Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa.
Ofosu FA; Hirsh J; Esmon CT; Modi GJ; Smith LM; Anvari N; Buchanan MR; Fenton JW; Blajchman MA
Biochem J; 1989 Jan; 257(1):143-50. PubMed ID: 2920007
[TBL] [Abstract][Full Text] [Related]
31. Prothrombin activation by prothrombinase in a tubular flow reactor.
Billy D; Speijer H; Willems G; Hemker HC; Lindhout T
J Biol Chem; 1995 Jan; 270(3):1029-34. PubMed ID: 7836355
[TBL] [Abstract][Full Text] [Related]
32. Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation.
Heeb MJ; Mesters RM; Fernández JA; Hackeng TM; Nakasone RK; Griffin JH
Thromb Haemost; 2013 Aug; 110(2):275-82. PubMed ID: 23892573
[TBL] [Abstract][Full Text] [Related]
33. Molecular and functional characterization of a natural homozygous Arg67His mutation in the prothrombin gene of a patient with a severe procoagulant defect contrasting with a mild hemorrhagic phenotype.
Akhavan S; De Cristofaro R; Peyvandi F; Lavoretano S; Landolfi R; Mannucci PM
Blood; 2002 Aug; 100(4):1347-53. PubMed ID: 12149217
[TBL] [Abstract][Full Text] [Related]
34. Neutralization of factor X activity by factor X-specific monoclonal antibodies.
Ouellette LA; Messier TL; Church WR
Blood Coagul Fibrinolysis; 1992 Oct; 3(5):563-74. PubMed ID: 1450323
[TBL] [Abstract][Full Text] [Related]
35. Apixaban inhibition of factor Xa: Microscopic rate constants and inhibition mechanism in purified protein systems and in human plasma.
Luettgen JM; Knabb RM; He K; Pinto DJ; Rendina AR
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):514-26. PubMed ID: 21171894
[TBL] [Abstract][Full Text] [Related]
36. Regulation of activated protein C by factor Xa.
Jane SM; Hau L; Salem HH
Blood Coagul Fibrinolysis; 1991 Dec; 2(6):723-9. PubMed ID: 1839223
[TBL] [Abstract][Full Text] [Related]
37. Assembly of the prothrombinase complex enhances the inhibition of bovine factor Xa by tick anticoagulant peptide.
Krishnaswamy S; Vlasuk GP; Bergum PW
Biochemistry; 1994 Jun; 33(25):7897-907. PubMed ID: 8011652
[TBL] [Abstract][Full Text] [Related]
38. Pseutarin C, a prothrombin activator from Pseudonaja textilis venom: its structural and functional similarity to mammalian coagulation factor Xa-Va complex.
Rao VS; Kini RM
Thromb Haemost; 2002 Oct; 88(4):611-9. PubMed ID: 12362232
[TBL] [Abstract][Full Text] [Related]
39. C-terminal residues 621-635 of protein S are essential for binding to factor Va.
Heeb MJ; Kojima Y; Rosing J; Tans G; Griffin JH
J Biol Chem; 1999 Dec; 274(51):36187-92. PubMed ID: 10593904
[TBL] [Abstract][Full Text] [Related]
40. Molecular recognition sites on factor Xa which participate in the prothrombinase complex.
Chattopadhyay A; James HL; Fair DS
J Biol Chem; 1992 Jun; 267(17):12323-9. PubMed ID: 1601896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
